US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,069.85

+7.400.36%

Number of Gainers:429

Number of Losers:579

Number of Flat:16

PE:- -

High:2,077.51

Open:2,062.51

Low:2,062.43

Close:2,062.36

Volume:3.64B

Turnover:429.02B

Market Cap:96.36T

Float Cap:90.21T

Loading ...

Synchrony Financial Schedules Third-Quarter Results Release and Conference Call

Oracle Named a Leader in Idc Marketscape: Worldwide Life Sciences R&D

THOMSON REUTERS

Adagene Says China NMPA Clears IND for Adg138 HER2xCD3 Bispecific T-Cell Engager

Factset - Announces Acquisition of Bcc Group International

THOMSON REUTERS

Factset - Acquisition not Expected to Materially Impact Factset's Financial Results

THOMSON REUTERS

Marist University and Ibm Launch Innovation Incubator with Ibm Z17, Expanding 50-Year Partnership to Advance AI Research and Student Career Readiness

THOMSON REUTERS

Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services

THOMSON REUTERS

Oracle Named a Leader in the 2026 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises

THOMSON REUTERS

Rhythm Pharmaceuticals Announces Health Canada Approval of Imcivree® (Setmelanotide) for Weight Management in Adult and Pediatric Patients 4 Years of Age and Older with Acquired Hypothalamic Obesity

THOMSON REUTERS

Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria

THOMSON REUTERS

Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts

THOMSON REUTERS

Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial

THOMSON REUTERS

Lantheus Receives Final FDA Approval for Bravnetsa™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA Has Determined to be Bioequivalent and Therapeutically Equivalent to Lutathera® for the Treatment of Gep-Nets

THOMSON REUTERS

Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

Press Release: Century Lithium Advances PLANS for CHLOR-Alkali PLANT

Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

Breakingviews-Paramount’s M&A Win Seals Showbiz’s Hamilton Fever

Arm Stock Forecast: ARM Breaks $299 as Agentic AI Re-Rates the CPU Story

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4585/news?page=303"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4585","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4585\",,,,,undefined,":{"symbol":"BK4585","market":"US","secType":"PLATE","nameCN":"ETF & Stock Investment","latestPrice":2069.7625,"timestamp":1790795755143,"preClose":2062.3596,"halted":0,"volume":3638487428,"delay":0,"changeRate":0.003589,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":7.402832,"latestTime":"09-30 15:15:55 EDT","open":2062.5142,"high":2077.513,"low":2062.4258,"amount":429017597683.0155,"amplitude":0.007315,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790798400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.196177,"peRate":25.339788,"turnoverRate":0.006088,"increases":425,"decrements":584,"flats":8,"marketCap":96357323640020,"floatMarketCap":90210092336076.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4585\",,,,,undefined,":{"symbol":"BK4585","high":2077.513,"amplitude":0.007315,"preClose":2062.3596,"low":2062.4258,"pbRate":"5.196177","latestPrice":2069.8528,"volume":3639267251,"delay":0,"open":2062.5142,"prevYearClose":1827.5802,"prevWeekClose":2079.4448,"prevMonthClose":2063.9097,"prevQuarterClose":2017.711,"fiveDayClose":2069.4614,"twentyDayClose":2048.795,"sixtyDayClose":2019.7522,"secType":"PLATE","market":"US","turnoverRate":0.006089,"peRate":25.339788,"marketCap":96357354686804,"floatMarketCap":90210400690380.5,"timestamp":1790795759291,"nameCN":"ETF & Stock Investment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4585\",,,,undefined,":{"bkCode":"BK4585","up":429,"down":579,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4585\",pageSize:20,pageCount:303,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669141137","title":"Synchrony Financial Schedules Third-Quarter Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141137","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141137?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:01","pubTimestamp":1790078467,"startTime":"0","endTime":"0","summary":"Synchrony Financial schedules third-quarter results release and conference callSynchrony schedules third-quarter 2026 results release for Oct. 20, 2026, around 6 a.m. ET on www.investors.synchrony.com","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDLb2s0HH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU1861217088.USD","LU2360107671.USD","BK4585","BK4588","LU0106831901.USD","SYF","BK4166","BK4561","LU1791807156.HKD","LU1861220207.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141901","title":"Oracle Named a Leader in Idc Marketscape: Worldwide Life Sciences R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141901?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:01","pubTimestamp":1790078460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUARDF0H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336760.USD","LU0889565833.HKD","LU0861579265.USD","LU0353189680.USD","LU2237957811.SGD","LU1989764664.SGD","SG9999003800.SGD","IE00BMPRXQ63.HKD","LU0965509010.AUD","LU2896262040.SGD","IE00B775SV38.USD","LU1935042991.SGD","LU0348723411.USD","LU1691799644.USD","LU1069347547.HKD","LU1720051017.SGD","LU0965508806.USD","LU0980610538.SGD","LU2458330169.SGD","LU0157215616.USD","LU1035773651.USD","LU0648001328.SGD","LU1934455863.HKD","LU2054465674.USD","IGV","ORCS","IE0004445239.USD","LU0109392836.USD","LU0208291251.USD","BK4528","ORCL","LU2108987350.USD","LU1037948897.HKD","LU1037948541.HKD","LU0323591593.USD","LU0081259029.USD","IE00B19Z3B42.SGD","LU0320765489.SGD","LU0965509283.SGD","LU2237957902.USD","BK4585","LU0957808578.USD","LU1548497426.USD","IE00BN8TJ469.HKD","LU0444973449.USD","LU0878866978.SGD","OGIG","LU0130102774.USD","IE0002270589.USD","ORAC","BK4538","LU1852331112.SGD","LU0234572021.USD","LU0198837287.USD","BK4516","IE00BMPRXN33.USD","LU0210536198.USD","LU0965509101.SGD","LU1934455194.USD","IE00BBT3K403.USD","LU2250418816.HKD","LU0068578508.USD","LU0949170772.SGD","LU2746668461.USD","ORCX","SG9999011175.SGD","LU1489326972.SGD","LU0234570918.USD","LU1235294995.USD","LU1642822529.SGD","ORCZ","IE00BMPRXR70.SGD","LU1366192091.USD","LU1429558221.USD","LU0175139822.USD","LU1989772840.SGD","LU0417517546.SGD","LU1003077747.HKD","LU0289960550.SGD","IE00B3S45H60.SGD","LU2746668974.SGD","LU2087625088.SGD","ORCU","IE00B7SZLL34.SGD","LU0661504455.SGD","BK4097","IE00BLSP4239.USD","LU1803068979.SGD","TDIV","LU0056508442.USD","LU1934455277.USD","LU2860962120.EUR","LU0738911758.USD","LU2458330243.SGD","BK4534","LU1506573853.SGD","SORCLmain","LU0476273544.USD","LU1989764748.USD","LU0314106906.USD","LU0444971666.USD","LU1435385759.SGD","LU1935042488.USD","IE00B19Z3581.USD","LU1201861249.SGD","LU1823568750.SGD","BK4581","LU0433182093.SGD","LU0985489474.SGD","LU1935043536.SGD","LU1366333091.USD","BK4588","BK4533","LU0719512351.SGD","LU2357305700.SGD","LU1720051108.HKD","LU0553294199.USD","SG9999001424.SGD","LU0353189763.USD","LU2326559502.SGD","LU2543165471.USD","LU0082616367.USD","IE00BLSP4452.SGD","LU0256863811.USD","LU1989772923.USD","LU2360106780.USD","LU1935042215.USD","LU0070302665.USD","IE00B5949003.HKD","LU0545039389.USD","LU2236285917.USD","BK4543","IE0009356076.USD","LU1935043023.USD","LU1046421795.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669929141","title":"Adagene Says China NMPA Clears IND for Adg138 HER2xCD3 Bispecific T-Cell Engager","url":"https://stock-news.laohu8.com/highlight/detail?id=2669929141","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669929141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078457,"startTime":"0","endTime":"0","summary":"Adagene says China NMPA clears IND for ADG138 HER2xCD3 bispecific T-cell engagerChina’s NMPA cleared Adagene’s IND for ADG138, a double-masked HER2xCD3 bispecific T-cell engager for advanced solid tum","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL9kk4jC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2V16.EUR","BCDF","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","LU2210150020.SGD","NDAQ","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419521","title":"Factset - Announces Acquisition of Bcc Group International","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419521","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419521?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078450,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210149790.SGD","FDS","BK4585","LU2095319765.USD","BK4588","BK4112","BK4567","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141909","title":"Factset - Acquisition not Expected to Materially Impact Factset's Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141909","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141909?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078450,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0MQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210149790.SGD","FDS","BK4585","LU2095319765.USD","BK4588","BK4112","BK4567","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141605","title":"Marist University and Ibm Launch Innovation Incubator with Ibm Z17, Expanding 50-Year Partnership to Advance AI Research and Student Career Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141605","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141605?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078411,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA77QRVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1894683264.USD","SKYY","LU0321505868.SGD","BK4579","BK4543","SIBM0main","TDIV","IBM","LU1236620834.HKD","LU1674673428.USD","BK4585","BK4134","BK4533","IBX","LU1430594728.SGD","BK4534","BK4575","LU0868494617.USD","LU1674673691.USD","WQTM","LU1894683348.USD","LU1883839398.USD","BK4612","LU0321505439.SGD","LU1236620750.USD","LU1585245621.USD","LU1880398471.USD","BK4602","LU1778281490.HKD","LU1880398554.USD","BK4538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141672","title":"Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141672?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078409,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABYYTYR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2458330169.SGD","LU0980610538.SGD","LU1003077747.HKD","IE00BLSP4452.SGD","WIT","BK4534","LU1935043023.USD","LU2896262040.SGD","BK4097","IGV","LU1989772923.USD","IE00B5949003.HKD","LU0157215616.USD","LU0198837287.USD","LU1069347547.HKD","SG9999011175.SGD","BK4581","LU0444973449.USD","LU1720051017.SGD","SG9999001424.SGD","LU2236285917.USD","LU0353189680.USD","IE00B3S45H60.SGD","LU0965508806.USD","LU0109392836.USD","LU0648001328.SGD","EDOG","ORCX","LU0320765489.SGD","IE00BBT3K403.USD","BK4134","IE00BMPRXN33.USD","IE00B19Z3581.USD","LU0314106906.USD","LU0661504455.SGD","LU1035773651.USD","LU1642822529.SGD","TDIV","LU1934455863.HKD","LU1489326972.SGD","LU1803068979.SGD","LU0070302665.USD","BK4588","LU0965509101.SGD","IE00B7SZLL34.SGD","LU0878866978.SGD","LU1989772840.SGD","LU1934455194.USD","LU2746668461.USD","LU0889565833.HKD","LU1691799644.USD","IE00BMPRXQ63.HKD","LU1815336760.USD","ORCL","LU1989764664.SGD","LU0068578508.USD","LU0719512351.SGD","IE00B775SV38.USD","LU2237957811.SGD","LU0965509283.SGD","IE00BMPRXR70.SGD","LU0081259029.USD","LU1548497426.USD","LU0056508442.USD","LU0965509010.AUD","LU1935042215.USD","LU0256863811.USD","LU1935043536.SGD","OGIG","IE00BN8TJ469.HKD","LU1720051108.HKD","LU1037948897.HKD","ORAC","LU0949170772.SGD","BK4533","LU0738911758.USD","LU1037948541.HKD","ORCU","LU0985489474.SGD","LU2054465674.USD","BK4516","LU2360106780.USD","BK4538","LU0082616367.USD","BK4543","LU0348723411.USD","LU1823568750.SGD","SG9999003800.SGD","LU0234572021.USD","LU1235294995.USD","LU1506573853.SGD","LU2250418816.HKD","LU1201861249.SGD","LU0289960550.SGD","LU0130102774.USD","LU0417517546.SGD","LU2543165471.USD","LU2357305700.SGD","BK4523","IE0002270589.USD","LU1366333091.USD","LU2860962120.EUR","LU1429558221.USD","LU1852331112.SGD","LU2108987350.USD","SORCLmain","IE00B19Z3B42.SGD","LU1989764748.USD","LU1435385759.SGD","LU0433182093.SGD","LU0208291251.USD","IE0004445239.USD","LU0175139822.USD","LU0323591593.USD","ORCS","LU1366192091.USD","LU0861579265.USD","LU0444971666.USD","LU0234570918.USD","LU2458330243.SGD","LU2087625088.SGD","LU0553294199.USD","LU2237957902.USD","BK4585","LU0353189763.USD","LU2746668974.SGD","IE0009356076.USD","LU0545039389.USD","IE00BLSP4239.USD","LU1935042991.SGD","ORCZ","LU0957808578.USD","LU1046421795.USD","LU1935042488.USD","LU0476273544.USD","LU1934455277.USD","BK4528","LU2326559502.SGD","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669956141","title":"Oracle Named a Leader in the 2026 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=2669956141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669956141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAB1KBP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BMPRXN33.USD","LU0965508806.USD","LU0070302665.USD","LU0433182093.SGD","SG9999011175.SGD","LU0234572021.USD","ORCL","LU1435385759.SGD","LU2746668974.SGD","LU2236285917.USD","LU2860962120.EUR","LU1003077747.HKD","LU0081259029.USD","LU0738911758.USD","LU1852331112.SGD","LU2458330169.SGD","IE00BLSP4452.SGD","LU0068578508.USD","IE00BN8TJ469.HKD","LU1934455863.HKD","LU2746668461.USD","LU0130102774.USD","LU0444973449.USD","IE00BBT3K403.USD","BK4581","LU1235294995.USD","LU0985489474.SGD","LU0175139822.USD","BK4534","BK4097","LU0082616367.USD","BK4533","ORCX","LU0157215616.USD","OGIG","IGV","LU1548497426.USD","LU0198837287.USD","LU0109392836.USD","LU0878866978.SGD","LU0889565833.HKD","LU2543165471.USD","LU2326559502.SGD","LU1366333091.USD","LU1815336760.USD","LU0965509101.SGD","ORCS","LU0965509283.SGD","IE0004445239.USD","BK4588","IE00B3S45H60.SGD","LU0289960550.SGD","SG9999001424.SGD","LU1201861249.SGD","LU0353189680.USD","LU0980610538.SGD","LU2360106780.USD","IE00B19Z3B42.SGD","LU1935042991.SGD","LU1069347547.HKD","LU1935043023.USD","TDIV","LU2896262040.SGD","LU0348723411.USD","LU1037948541.HKD","LU0353189763.USD","LU1934455194.USD","LU0208291251.USD","LU1035773651.USD","BK4528","LU0323591593.USD","LU1989772840.SGD","IE00B19Z3581.USD","LU2250418816.HKD","LU1935042488.USD","LU1989764664.SGD","SG9999003800.SGD","LU2054465674.USD","LU2237957902.USD","LU2458330243.SGD","LU0210536198.USD","IE00B7SZLL34.SGD","LU0553294199.USD","LU2357305700.SGD","IE00BLSP4239.USD","LU0957808578.USD","LU1046421795.USD","LU0661504455.SGD","LU1803068979.SGD","LU0861579265.USD","IE00B775SV38.USD","IE0002270589.USD","IE0009356076.USD","LU1366192091.USD","ORCZ","LU1823568750.SGD","LU0320765489.SGD","LU0949170772.SGD","IE00B5949003.HKD","LU0545039389.USD","BK4585","LU0256863811.USD","BK4538","IE00BMPRXQ63.HKD","LU1429558221.USD","LU0476273544.USD","ORAC","ORCU","LU1935042215.USD","LU0719512351.SGD","SORCLmain","LU2087625088.SGD","LU0056508442.USD","LU1642822529.SGD","LU1720051017.SGD","LU1934455277.USD","LU0444971666.USD","LU1691799644.USD","LU1506573853.SGD","LU0965509010.AUD","LU0314106906.USD","LU0417517546.SGD","LU1989764748.USD","LU0234570918.USD","LU1489326972.SGD","LU2108987350.USD","LU0648001328.SGD","LU1037948897.HKD","BK4543","LU2237957811.SGD","LU1720051108.HKD","IE00BMPRXR70.SGD","LU1989772923.USD","BK4516","LU1935043536.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141601","title":"Rhythm Pharmaceuticals Announces Health Canada Approval of Imcivree® (Setmelanotide) for Weight Management in Adult and Pediatric Patients 4 Years of Age and Older with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141601?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA3C2WMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","BK4588","RYTM","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419861","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Reduces Uacr by -42.7% at Week 13 in Amkd with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419861","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419861?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIB","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1674673691.USD","LU2362541273.HKD","BK4139","LU2236285917.USD","LU2237438978.USD","LU2362540622.SGD","LU0823416689.USD","LU2324357040.USD","IE0002141913.USD","PBE","LU2468319806.SGD","LU1069344957.HKD","SGXZ57979304.SGD","LU0256863811.USD","GNMX","LU2362541513.USD","LU0289739699.SGD","LU2456880835.USD","IE00B19Z9P08.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU1430594728.SGD","IE0002270589.USD","IE00B2B36J28.USD","VRTX","LU0079474960.USD","LU1778281490.HKD","LU1093756325.SGD","IE00B894F039.SGD","IE0009355771.USD","IE00B19Z9Z06.USD","IDNA","LU0417517546.SGD","LU2417539215.USD","LU0234570918.USD","IE00B19Z3581.USD","LU2462157665.USD","LU1585245621.USD","LU1093756168.USD","BBH","IBBQ","LU1674673428.USD","LU0109394709.USD","IBB","BK4585","TBXU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419041","title":"Vertex Pharmaceuticals Incorporated - Inaxaplin Generally Safe and Well Tolerated in Both Amkd Cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419041?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0079474960.USD","IBB","BK4533","PBE","LU0234570918.USD","LU1585245621.USD","LU2237438978.USD","VRTX","BK4532","BK4567","LU1674673428.USD","LU2362541513.USD","GNMX","LU2089984988.USD","LU0432979614.USD","LU1035775433.USD","IE0002270589.USD","LU2456880835.USD","LU0109394709.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU0256863811.USD","BK4585","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2324357040.USD","IDNA","LU0058720904.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU0889565916.HKD","LU1069344957.HKD","BIB","IE00BJT1NW94.SGD","SG9999001176.USD","BBH","BK4588","IE00B19Z9P08.USD","SG9999001176.SGD","LU2462157665.USD","LU0061475181.USD","TBXU","SG9999013999.USD","LU1093756325.SGD","IBBQ","LU2417539215.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141954","title":"Vertex Announces Positive Results from Phase 2B Amplified Study of Inaxaplin in Additional Populations of People with Apol1-Mediated Kidney Disease (Amkd) and Completion of Enrollment in the Phase 2/3 Amplitude Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141954?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA6RPXRQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNMX","BIB","LU1674673691.USD","LU0823416689.USD","LU0061475181.USD","VRTX","LU1069344957.HKD","TBXU","LU0320765992.SGD","LU0234570918.USD","LU2089984988.USD","SG9999013999.USD","IE00B19Z9P08.USD","BK4139","SGXZ57979304.SGD","BK4567","LU2456880835.USD","LU2236285917.USD","LU0058720904.USD","BK4585","BK4532","LU1585245621.USD","BBH","LU0079474960.USD","LU0889565916.HKD","IBBQ","IE00B4R5TH58.HKD","LU1674673428.USD","IE00BJT1NW94.SGD","SG9999001176.USD","LU0417517546.SGD","LU0256863811.USD","IE0002270589.USD","LU0432979614.USD","LU0109394709.USD","IE00B19Z3581.USD","PBE","IE00B2B36J28.USD","BK4533","IBB","IE0002141913.USD","LU0289739699.SGD","LU1778281490.HKD","IE00B19Z3B42.SGD","LU1093756325.SGD","IE00BZ9MQY76.HKD","LU2237438978.USD","SG9999001176.SGD","LU1035775433.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141955","title":"Lantheus Receives Final FDA Approval for Bravnetsa™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA Has Determined to be Bioequivalent and Therapeutically Equivalent to Lutathera® for the Treatment of Gep-Nets","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141955?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA7HQSTV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNTH","BK4585","BK4588","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669890142","title":"Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System","url":"https://stock-news.laohu8.com/highlight/detail?id=2669890142","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669890142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366242/0/en/natural-design-amplified-smith-nephew-announces-fda-510-k-clearance-and-first-surgical-cases-of-landmark-total-knee-system.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","SNN","ASC","BK4082","BK4144","BK4588","TSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669882142","title":"PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2669882142","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669882142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor nave patients Company continues to prioritize PDS0301 in metastatic colorectal cancer (mCRC) while pursuing partn","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366230/37149/en/pds-biotech-announces-publication-of-versatile-002-phase-2-clinical-trial-results-of-pds0101-with-pembrolizumab-in-hpv16-positive-recurrent-and-or-metastatic-r-m-head-and-neck-canc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ORR","BK4585","IDNA","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669414711","title":"Press Release: Century Lithium Advances PLANS for CHLOR-Alkali PLANT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414711","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669414711?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"supply chain, supporting lithium and battery-materials processing, rare. earth element separation, and precious and specialty metals production,in addition to broader industrial and household uses.-- The proposed CA Plant would produce chlorine, hydrochloric acid and. sodium hydroxide from sodium chloride, water and electricity, at a target. commercial production rate of 300 short tons per day  of chlorine,with provision to double capacity to 600 st/d depending on regional. demand and the supply needs of Angel Island.-- Century Lithium has entered into eight non-binding Memoranda of. Understanding  with third parties for offtake arrangements that. could collectively account for the full initial production of the. -- Candidate sites in Nevada and Utah were evaluated against feedstock,power, rail access, market proximity, land tenure, and permitting. -- The proposed CA Plant would use modern, proven technology in a location. -- Site due diligence is underway; the next step will be securi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","FXZ","BK4168","SETM","TSL","TSLS","TSLW","TSLG","TSLZ","TSII","BK4585","TLA","LIT","TESC","TSLI","TSLP","09366","TSYY","TSLR","TSLT","BK4516","TSLL","CA","TSLO","TESL","CRSH","09766","07366","CNBKA","TEST","07766","CYDVF","ELOL","TSLQ","TSDD","TSLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142898","title":"Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142898","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142898?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"HOUSTON, Sept.  22, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing multi-antigen recognizing (MAR)-T cell therapies for the trea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366273/0/en/marker-therapeutics-highlights-expanded-manufacturing-support-of-cdmo-partner-following-formation-of-kincellis-advanced-therapies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BD0PCF45.HKD","LENZ","BK4007","GB00B4LPDJ14.GBP","BK4157","IE00B66KJ199.SGD","LU1718418525.SGD","BK4139","LU0274383776.USD","GB00B4QBRK32.GBP","CAR","MAR","IE0031619046.USD","LU2404859667.USD","IE00B0T0GQ85.USD","LU2089985449.USD","IE00B19Z4B17.USD","BK4142","LU2404859741.USD","BK4022","LU0757428866.USD","IE00B1G9WX41.USD","LU1815336091.USD","BK4230","AEIS","CDMO","BK4585","LU0690374961.EUR","IE00B95QR487.USD","LU2931357623.SGD","EES","BK4588","LU0690374615.EUR","BK4539","IE00B7SZL793.SGD","IE00B45NX917.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142894","title":"OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142894","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142894?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisersusing The Trade DeskWALTHAM, Mass","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366239/0/en/optimizerx-brings-net-new-authenticated-hcp-reach-to-the-trade-desk-through-openpath.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","BK4588","DSP","BK4550","BK4023","CGCV","NOBL","VHT","RKNG","TCAF","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141923","title":"Breakingviews-Paramount’s M&A Win Seals Showbiz’s Hamilton Fever","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141923","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141923?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"RPT-BREAKINGVIEWS-Paramount’s M&A win seals showbiz’s Hamilton feverNEW YORK, Sept 21 (Reuters Breakingviews)-Alexander Hamilton, the first US treasury secretary, is the favorite founding father of sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL6N45D0WI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","BK4585","BK4125","LU0130102774.USD","LU0477156953.USD","LU0648001328.SGD","LU1201861249.SGD","PSKY","BK4108","BK4588","LU0149725797.USD","BK4598","WBD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141492","title":"Arm Stock Forecast: ARM Breaks $299 as Agentic AI Re-Rates the CPU Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141492","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141492?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"TradingKey - Arm surges 17.16% as agentic AI revives the CPU trade, while a breakout above $299.41 puts 344.96-345.01 in focus.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20240911/de6bef4a3a2149139c7fe80c29fabc7bARM.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20240911/de6bef4a3a2149139c7fe80c29fabc7bARM.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262180017-arm-stock-forecast-agentic-ai-299-breakout-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348723411.USD","AIPI","LU0081259029.USD","TRFK","IE00BMPRXN33.USD","BK4585","HK0000914660.USD","BK4588","QQQA","ARMA","IE00BMPRXR70.SGD","BK4609","SPRX","BK4141","LU0266013472.USD","ARMU","ARMW","IE00BMPRXQ63.HKD","HK0000914686.HKD","LU2543165471.USD","ARM","LU1232071149.USD","BK4543","ARMG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":866,"pageCount":303,"totalSize":17311,"code":"91000000","status":"200"}]}}